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The obvious symptoms of schizophrenia are of cognitive and psychopathological nature.
However, schizophrenia affects also visual processing which becomes particularly evident
when stimuli are presented for short durations and are followed by a masking stimulus.
Visual deficits are of great interest because they might be related to the genetic variations
underlying the disease (endophenotype concept). Visual masking deficits are usually
attributed to specific dysfunctions of the visual system such as a hypo- or hyper-active
magnocellular system. Here, we propose that visual deficits are a manifestation of a
general deficit related to the enhancement of weak neural signals as occurring in all other
sorts of information processing. We summarize previous findings with the shine-through
masking paradigm where a shortly presented vernier target is followed by a masking
grating. The mask deteriorates visual processing of schizophrenic patients by almost an
order of magnitude compared to healthy controls. We propose that these deficits are
caused by dysfunctions of attention and the cholinergic system leading to weak neural
activity corresponding to the vernier. High density electrophysiological recordings (EEG)
show that indeed neural activity is strongly reduced in schizophrenic patients which we
attribute to the lack of vernier enhancement. When only the masking grating is presented,
EEG responses are roughly comparable between patients and control. Our hypothesis
is supported by findings relating visual masking to genetic deviants of the nicotinic α7
receptor (CHRNA7).
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VISION AND SCHIZOPHRENIA: FINDINGS AND A
FRAMEWORK
The most obvious symptoms of schizophrenia are related to psy-
chopathology (e.g., delusions, hallucinations, negative symptoms,
and disorganization syndrome) and cognitive deficits such as
working memory and attention. In addition, schizophrenic show
strong perceptual deficits. The causes of schizophrenia may be
found on various levels including ones which are not directly
linked to phenomenology. Here, we propose that visual deficits
in schizophrenic patients are not related to visual deficits per se
but are a manifestation of a general dysfunction of enhancing and
stabilizing neural activity.
VISUAL BACKWARD MASKING DEFICITS
To understand visual deficits in schizophrenia, we are using a
backward masking procedure, called the shine-through effect
(Herzog and Koch, 2001; Herzog and Fahle, 2002). This mask-
ing technique comes with a two step procedure. First, a vernier
stimulus is presented which comprises two vertical bars slightly
offset in the horizontal direction. Vernier offset discrimination is
a challenging task. Offsets are often smaller than the diameter of
a photoreceptor in the retina and, therefore, offset discrimination
needs information integration across nearby neurons. Per trial,
the vernier is randomly offset either to the left or right.
Observers indicate the offset direction. For long vernier dura-
tions, schizophrenic patients show no or only very weak deficits.
We presented the vernier with different durations starting off with
a duration of 150ms. For this duration, we found thresholds of
41.1 arc sec in patients and 33.0 arc sec in controls. Block by block,
we reduced the vernier duration further until observers could not
reliably perceive a vernier offset size of 0.66 arc min. This critical
vernier duration was 43.2ms for patients and 27.4ms for controls
(Chkonia et al., 2010). These results are in line with previous stud-
ies in which also significant, but moderate, visual deficits were
found with different types of visual stimuli (e.g., Saccuzzo et al.,
1974; Braff and Saccuzzo, 1981; Saccuzzo and Schubert, 1981).
To challenge the visual system, we added to the spatially
demanding vernier offset discrimination task a temporal chal-
lenge by presenting a mask after the vernier. For each observer, we
presented the vernier with his/her individual duration as deter-
mined in the first step. After the vernier, a blank screen followed,
i.e., an inter-stimulus-interval (ISI), and then a mask. In the basic
masking conditions, the mask comprised 5 or 25 aligned verniers,
i.e., verniers without an offset (Figure 1).
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FIGURE 1 | Step 1. We presented a vernier without a mask (not shown). In
a block of 80 trials, we presented the vernier with a certain duration and
determined adaptively the offset size for which 75% correct responses
occurred. In successive blocks, we reduced the vernier duration (VD) from
150ms to the VD for which the vernier offset size was about 0.66′
(arc min). These critical vernier durations were 43.2ms for patients and
27.4ms for controls on average. Step 2. The vernier was presented with
the individual vernier duration of each observer, as determined in step 1.
Next a blank screen, i.e., an inter-stimulus-interval (ISI), followed and then a
masking grating. The vernier offset was fixed and we adaptively varied the
ISI between vernier disappearance and the grating onset. We determined
the SOA for which 75% correct responses occurred. We plot results as
SOA = VD + ISI. Patients need much longer SOAs than controls. The main
effect is due to the prolonged ISIs rather than the only slightly longer
vernier durations. Reprinted with permission from Herzog et al. (2004).
Whereas we varied the vernier offset in the previous condi-
tion, here, we kept the vernier offset constant and varied the ISI
between the vernier and the mask. We determined the critical ISI
for which observers reached 75% correct responses. We found
a tremendous deterioration of performance for the schizophre-
nia patients. With the 25 element grating mask, schizophrenia
patients needed SOAs of about 150ms whereas controls needed
only about 30ms (Herzog et al., 2004; Chkonia et al., 2010).
With the 5 element grating mask, patients needed SOAs of about
240ms while controls needed only about 80ms (Herzog et al.,
2004). Hence, schizophrenic patients show very strong visual
deficits when their visual system is challenged both spatially
and temporally. These results are well in agreement with previ-
ous studies on masking where patients showed strong masking
deficits even when target duration was adjusted for each observer
individually (e.g., Braff and Saccuzzo, 1981; Green et al., 1994a;
Cadenhead et al., 1997).
VISUAL BACKWARD MASKING DEFICITS ARE TARGET
ENHANCEMENT DEFICITS
In the next, third step, we used for each observer his or her
individual vernier duration and the individual ISI of the 25 ele-
ment mask, i.e., we used on average an SOA of 150ms for the
patients and an SOA of 30ms for the controls. In this condi-
tion, we determined the vernier offset size adaptively, i.e., we
determined the offset for which 75% correct responses occurred.
Because of these normalized, individual values, performance was
comparable across all observers for the 25 element grating, i.e., as
aimed for.
Next, we removed 2 elements from the 25 element grat-
ing creating two gaps, thus, singling out a central grating with
5 elements from two peripheral gratings with 9 elements each
(Figure 2). In healthy controls, we showed previously that this
gap grating leads to much stronger masking than the homoge-
nous 25 element grating (Herzog and Koch, 2001). We proposed
that complex, spatial processing causes the deterioration of per-
formance because nearby elements group together and ungroup
from the peripheral elements. Our computer simulations showed
how vernier related activity is dynamically suppressed with the
gap grating but not with the homogeneous 25 element grating
(Herzog et al., 2003).
The rationale of step 3 is as follows. If the gaps, for example,
are blurred, performance should, paradoxically, be better than if
vision is intact and the gaps are clearly processed. Hence, deterio-
ration of performance with the gap grating indicates intact spatial
processing. We found that, indeed, patients showed as strong per-
formance deficits as controls (Figure 2). The very same holds true
for temporal manipulations. We presented a 5 element grating
for only 20ms before the 25 element grating lasting for 280ms.
Because of the short duration of 20ms, the 5 element grating is
invisible. Still, it exerts strong performance deficits by a factor
of about 5 compared to the 25 element grating. Schizophrenic
patients show very similar deteriorations. Hence, it seems that
spatial and temporal processing of the masking gratings is largely
intact in schizophrenic patients.
In a series of further experiments, we supported these results.
For example, we first deteriorated performance by adding small
lines to the 25 element grating. Then we added additional
horizontal lines which undid the deleterious effects of the ver-
tical lines. Again, performance in patients and controls was
rather similar (Schütze et al., 2007; Roinishvili et al., 2008).
Hence, it seems that spatio-temporal processing is largely intact
in the schizophrenic patients—after vernier duration and SOA
were adjusted individually. For this reason, we propose that
schizophrenic patients are just two steps from normal (in visual
processing). There is a moderate deficit for the unmasked
vernier, which could partially reflect long term suffering from
the disease. Adolescents with schizophrenia do not show such
deficits (Rund et al., 1996; Holzer et al., 2009; see also Saccuzzo
et al., 1974). Such deficits may also likely occur when peo-
ple are suffering, for example, from fever and other diseases
affecting attention and concentration. To compensate for these
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FIGURE 2 | A vernier was followed by a variety of gratings (the vernier is
not shown, only the masking gratings). (A) Because we used for each
observer his/her individual vernier duration and ISI, performance is roughly
the same in patients and controls when the 25 element grating follows the
vernier. Performance deteriorates significantly for the patients and healthy
controls if either a “gap grating” or a “5–25” element grating follows the
vernier. In the 5–25 grating, a 5 element grating is presented for 20ms
followed immediately by a 25 element grating for 280ms. Because of the
short duration, the 5 element grating is invisible. Performance deficits are
similar in patients and controls indicating, paradoxically, intact spatial and
temporal processing of the schizophrenic patients, i.e., patients seem to
process the gaps and the briefly presented 5 element grating “carefully.”
Were the gaps fully blurred or the 20ms 5 element grating smeared out,
performance would be on the level of the homogeneous 25 element grating
(#25). However, this is not the case. (B) (a) As in (A), performance of patients
and controls is roughly identical with the homogenous 25 element grating
because we used the individual vernier durations and ISIs. (b) Performance
strongly deteriorates by adding single collinear lines. (c) Horizontal contextual
lines yield a performance level comparable to the standard condition (a).
(c) Combining vertical and horizontal lines from the conditions (b) and (c)
improves performance compared to (b). The horizontal contextual lines
“counteract” the vertical lines. Again, it seems that patients “carefully”
process the task irrelevant vertical lines, reflected in the strong performance
deficits. This deterioration and the recovery from it by horizontal lines, is very
similar to the one of controls. Reprinted with permission from Herzog et al.
(2004) and Roinishvili et al. (2008).
deficits, we provided individually adjusted vernier durations
in the masking conditions. Here, we found dramatically dete-
riorated performance which we attribute to a reduced target
enhancement.
MULTIFACTORIAL TARGET ENHANCEMENT
It seems that visual processing of the masks is intact in schizo-
phrenic patients. We propose what is deficient in schizophrenia is
the processing of the target as a target, particularly, in demand-
ing situations when, for example, targets are presented briefly,
masked, or their contrast is low (e.g., Slaghuis, 2004). The tar-
get is the element of a visual scene which is task relevant. In
many everyday situations, there is no target, for example, when
observers just passively watch a scene or a movie. In the labora-
tory, many features or elements can be defined as the target for the
very same stimulus. For example, we may have varied the vernier
offset direction and, in addition, the length of the grating ele-
ments being a bit longer or shorter. In this example, we can ask
observers to attend to the vernier offset or to the length of the
grating elements. The stimuli are the same, just the tasks differ.
Likewise, in a soccer game, you may attend to the actions of the
players of team A, or B, or the behavior of other fans.
Vernier offset discrimination is a demanding task when the
vernier offset is small and its duration short. In this situation,
neural responses are weak and it may be necessary to boost the
corresponding weak neural signals to reach good performance.
One option is to use recurrent processing (Figure 3). This can
lead to strong and persistent neural signals even when the vernier
is not presented anymore on the screen. It may be that such recur-
rent processing is deteriorated in schizophrenia. Because there is
no mask, patients can reach the same performance level as con-
trols, after longer recurrent processing. Hence, there are no strong
performance deficits. When, however, a mask is presented, the
mask may override and interrupt the recurrent vernier process-
ing. To counteract, at least partially, the effects of such masks (and
other adverse effects), the human brain is equipped with further
mechanisms to enhance weak neural signals.
Neuromodulation and attention
We can only speculate on the mechanisms of target enhancement.
Next to recurrent processing, one obvious candidate is atten-
tion. Attention deficits are core deficits in schizophrenia (e.g.,
Cornblatt and Keilp, 1994; Nestor and O’Donnell, 1998; Green,
2006). There are many types of attention. One important type
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FIGURE 3 | Hypothetical mechanisms of target enhancement. (A) A
vernier is presented and processed along the visual hierarchy including the
retina, the LGN, the primary visual cortex V1, and higher visual areas.
Because of the very short presentations times (20–40ms), only a weak
neural response is elicited (small ticks next to the neurons indicated by the
blue diamonds). (B) If there is target enhancement by recurrent processing,
attention, ACh neuromodulation, or other factors, the weak response of the
vernier is amplified. Even if the vernier has disappeared on the screen, neural
responses may be present because of recurrent amplification. If a masking
grating follows the vernier (not shown), recurrent amplification is interrupted
and other forms of target enhancement are needed to reach good
performance. If target enhancement is dysfunctional, a weaker enhancement
leads to poorer performance (as in A). These considerations are highly
simplified and the underlying mechanisms are largely unknown. Attention is
likely to play an important role because without attention to the vernier,
performance is strongly deteriorated in healthy observers. Our main proposal
is that weak target stimuli need task-dependent enhancements and that
these may be dysfunctional in schizophrenic patients.
is selective visual attention. Visual attention can improve per-
formance substantially. For example, in a classical Posner cueing
paradigm, observers fixate a dot in the center of a computer
screen. A square appears randomly either on the left or right of
the fixation dot. Reaction times are much faster when the cue is
presented just before the square at the same location, i.e., when
attention can move to the target location before target presen-
tation (Posner and Petersen, 1990). Reaction times are longer
when there is no cue or when the cue appears to the “incorrect”
side. EEG recordings show higher amplitudes when the target
square is correctly cued compared to when not (Hillyard and
Anllo-Vento, 1998). Similarly, monkey studies have shown that
neural signals can be strongly enhanced when an element in a
visual scene is attended compared to when it is not attended
(Treue and Martínez-Trujillo, 1999; Maunsell and Cook, 2002).
Importantly, only weak, low contrast stimuli benefit from atten-
tion (Treue and Maunsell, 1996; Reynolds and Heeger, 2009).
We propose that a similar scenario applies to masking situations
where target stimuli are weak because of brief presentation times
(Figure 3).
Neuromodulation by the cholinergic system might be another
mechanism for target enhancement (Cullum et al., 1993;
Parasuraman and Greenwood, 2004; Deco and Thiele, 2009).
The cholinergic system projects to layer IV of the primary visual
cortex where retinal information first enters the visual cortex
(Gil et al., 1997; Disney et al., 2007). It is often proposed that
acetylcholine controls the influx of “external information” into
the cortex. For example, when concentrating on a difficult mathe-
matical problem in a noisy environment, acetylcholine may “shut
down” disturbing visual signals, e.g., from a TV screen. In con-
trast, acetylcholine boosts weak but important information. In
psychophysical experiments, targets are presented over and over
again in a stereotyped manner and thus target occurrence is pre-
dictable, i.e., acetylcholine release can be initiated before target
presentation (Sarter et al., 2009). Hence, a hypofunction of the
cholinergic system may explain deteriorated vision in schizophre-
nia (Figure 3).
This proposal is in line with several studies showing that the
nicotinic ACh system has significant impact on the mismatch
negativity (MMN) (Knott et al., 2012) and sensory gating in
schizophrenic patients (Freedman et al., 1997; Adler et al., 1998).
In addition, deficits of schizophrenic patients in P50 gating could
be improved by nicotine agonists (Adler et al., 2005; Zhang et al.,
2012). Hence, a dysfunction of the cholinergic system may be
involved in a large variety of dysfunctions including visual ones.
For simple tasks with large and high contrast stimuli, no target
enhancement is needed. Accordingly, in these conditions perfor-
mance is usually quite good in schizophrenic patients. When the
verniers are not the target they are likely to go unnoticed. This
makes sense because, in this case, vernier enhancement would
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just lead to amplification of a “disturbing” signal. Hence, tar-
get enhancement is activated only when an element is weak
and the task-relevant target. Particularly at this stage, deficits of
schizophrenia become evident.
However, at present, these considerations remain speculative.
There may be more mechanisms and systems that can up- or
down-regulate neural activity. In addition, the cholinergic system
is a complex system with combinations of several sub-systems
(nicotinic vs. muscarinic) which all (or some of them) may be
altered in schizophrenia in various combinations. It is likely that
not only one enhancing system is deficient in schizophrenia but
certain combinations of them.
In addition, very little is known on the effects of acetycholine
and attention on vision and how these systems relate to each other
and to other systems and mechanisms, including recurrent and
top-down neural activation. In addition, it is unclear to which
extent acetylcholine is involved in attention itself. Whatever the
neural mechanisms are, we propose that there are systems that
can enhance targets and that some of them are dysfunctional in
schizophrenia.
Genetics
Schizophrenic patients are usually heavy smokers (Dickerson
et al., 2013) and smoking is often considered a type of self-
medication which is very much in accordance with deficits in
the cholinergic system (Moran et al., 2012). In schizophrenia, the
gene for the alpha 7 receptor subunit was found to be related to
deficits in sensory gating (Raux et al., 2002; Houy et al., 2004;
Martin et al., 2007). In addition, visual acuity was found to be
low in CHRNA7 knockout mice (Origlia et al., 2012). We investi-
gated five single nucleotide polymorphism (SNPs) of CHRNA7
and found that one SNP correlated well with the diagnosis of
schizophrenia.Moreover, this SNP showed a high correlation with
backwardmasking deficits in the shine-through effect (Bakanidze
et al., 2009).
EEG
Our model of target enhancement is corroborated by our EEG
recordings (Plomp et al., 2013). We recorded brain activity with
64 electrodes and computed the global field power (GFP). The
GFP reflects overall brain activity. We determined performance in
four conditions (Figure 4A). First, only the vernier was presented.
Second, the vernier was followed immediately by the 25 element
grating (mean SOAof controls), or, third by an ISI and then by the
grating (mean SOA of patients). Fourth, only the grating was pre-
sented (no preceding vernier; observers were not aware that there
is no vernier because masking is so strong that the vernier is often
invisible also when presented). The GFP of patients was much
lower than the GFP of controls in the first three conditions where
the vernier was presented (Figure 4B). As a speculation, we like to
argue that the reduced GFP reflects a lack of target enhancement
of the vernier. The reduced neural activity becomes behaviorally
relevant only in the two masked conditions because, as we argue,
recurrent processing is disturbed by the mask and, thus, target
amplification is reduced. In the vernier only condition, longer
recurrent processing may compensate the reduced neural activity
(see Neuromodulation and Attention). Reduced EEG traces may
also be caused by other factors such as diminished neural excita-
tion. However, interestingly, EEG traces of patients and controls
were very similar in the mask only condition arguing against a
permanent deficit (Figure 4B).
DISCUSSION
We view visual masking deficits in schizophrenia as a manifes-
tation of a general deficit of target enhancement rather than as
a specific visual deficit such as a dysfunction of the magnocel-
lular system (see below). In this sense, visual dysfunctions in
schizophrenia allow a general view into the basic “mechanisms of
madness.” We suggest that mechanisms similar to target enhance-
ment may by deficient also in other visual and cognitive processes
of schizophrenic patients.
For example, schizophrenic patients show strong deficits in
the detection of low contrast stimuli (Slaghuis, 1998, 2004; Kéri
et al., 2004; Calderone et al., 2013). It remains an open ques-
tion whether these visual deficits are restricted to patients with
negative symptoms (e.g., Slaghuis, 1998) and to certain stim-
uli, such as low spatial frequency gratings (Kéri et al., 2004).
Delord et al. (2006) found that contrast detection thresholds of
schizophrenic patients were significantly poorer than those of
controls for all frequencies, arguing rather for a general visual
deficit. Patients show also strongly deteriorated performance for
high contrast stimuli when these stimuli are fragmented, i.e.,
where only parts of the contour of an object are visible. We like
to argue that all these tasks require strong attention and some
sort of task stabilization because information has to be inte-
grated, for example, across contour elements in a time consuming
manner.
In a similar fashion, we think that target enhancement is
crucial in cognition. For the basic continuous performance test
(CPT), performance is only slightly deteriorated in patients com-
pared to controls (Nuechterlein et al., 1992). However, when
stimuli are embedded in noise and, thus, contrast reduces, per-
formance of patients deteriorates much more strongly than
performance in controls. Effects are more pronounced when
a memory component is added (Nuechterlein et al., 1992;
Chkonia et al., 2010). We like to argue that these tasks, as the
masking paradigm, require mechanisms to stabilize information
across space and time, and that this ability is deteriorated in
schizophrenic patients. The cholinergic system makes projections
throughout the entire brain and can thus stabilize all sorts of pro-
cessing including the ones mentioned above (Nelson et al., 2005;
Deco andThiele, 2009; Bentley et al., 2011; Yakel, 2013). The same
holds true for attention.
Schizophrenic patients show also deficits in passive tests such
as the MMN (Olincy and Freedman, 2012), prepulse inhibition
(PPI), and P50 gating (Adler et al., 1991; Olincy et al., 2010). We
will argue below that we do not propose that dysfunctional tar-
get enhancement is the only deficit in schizophrenic patients. To
the contrary, we suggest that there are many deficits necessary to
create the full blown symptoms of schizophrenia. Hence, MMN
and P50 gating deficits may be of a different nature than masking
deficits. In this sense, it is surprising that nicotinic agonists can
compensate P50 deficits (Adler et al., 2005; Zhang et al., 2012)
and MMN deficits (Knott et al., 2012). In addition, we like to
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FIGURE 4 | (A) In the first condition, a vernier was presented for 30ms.
Observers discriminated the offset direction (here, a right offset is shown). In
the second and third conditions, the 30ms vernier was followed by a grating
either immediately (short SOA) or after a blank screen of 120ms (long SOA).
Fourth, we presented only the masking grating. (B) The global field power
(GFP) for patients and controls in the 4 stimulus conditions showed clear
differences in peak amplitude between patients and controls, at around
200ms [reprinted with permission from Plomp et al. (2013)].
mention that schizophrenic patients show also immune deficits
such as a diminished niacin skin response (Puri et al., 2001;
Messamore, 2012). Also these deficits can, surprisingly, be linked
to the cholinergic system (Gallowitsch-Puerta and Tracey, 2005).
Hence, cholinergic deficits may be much more fundamental and
not be related to target enhancement only.
Schizophrenic patients show often a strong degree of cognitive
disorganization affecting performance in a large variety of every-
day tasks. For this reason, cognitive disorganization is, next to
positive and negative symptoms a key aspect in the psychopathol-
ogy of schizophrenia. One century ago, Bleuler proposed that
loose associations are even the basic symptoms of schizophre-
nia and can cause delusions and hallucinations (Bleuler, 1911).
We found that persons with high scores of cognitive disorgani-
zation of schizotypy have problems focusing on tasks which may
be related to stabilizing task related information. Accordingly, we
found backward masking deficits in the shine-through paradigm
in healthy psychology students with high scores on cognitive
disorganization but not with high scores for the positive and
negative dimensions (Cappe et al., 2012).
We do not propose that attention and cholinergic dysfunc-
tions are necessary and sufficient for schizophrenia. Likewise, we
do not propose that target enhancement is necessary and suffi-
cient for schizophrenia. Quite to the contrary, we believe that
dysfunctional target enhancement is only one factor that can con-
tribute to schizophrenia. First, there are patients without target
enhancement deficits since not all patients have masking deficits.
On the other hand, healthy student observers can have (moder-
ate) masking deficits without an indication of the disease. Second,
there can be many causes for dysfunctional neural enhancements.
Attention and cholinergic modulation are just two examples.
Within the cholinergic system, there may be many deficits lead-
ing to a similar phenotype since the cholinergic system itself is a
complex system with two subsystems and various receptor types.
In addition, there may be many mutations that all can lead to
one dysfunction. For this reasons, we suggest that the study of
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endophenoytpes can be a successful tool to characterize subpop-
ulations of schizophrenia. Visual masking is only one potential
endophenotype.
ENDOPHENOTYPE CONCEPT
The shine-through masking paradigm is a potential endophe-
notype of schizophrenia. We found masking deficits not only
in schizophrenic patients but also in their unaffected relatives
(Chkonia et al., 2010). In addition, masking deficits were stable
for 1 year (Chkonia et al., 2010) and adolescents with psychosis
show masking deficits even before the manifestation of the dis-
ease (Holzer et al., 2009). Masking deficits are specific for the
spectrum of functional psychoses (bipolar, schizoaffective, and
schizophrenic patients) and were not found in depressed patients
and abstinent alcoholics (Chkonia et al., 2012). We like to men-
tion that visual backward masking can easily be controlled and
has a much better signal to noise ratio than most cognitive tests
(Chkonia et al., 2012).
THE DYSFUNCTION HYPOTHESIS OF THE MAGNOCELLULAR SYSTEM
Almost all current approaches on visual masking deficits in
schizophrenia propose a dysfunction of the magno-cellular sys-
tem based on the dual channel model of Breitmeyer and Ganz
(1976). Enhanced masking in schizophrenic patients is attributed
to either a hyperactive or hypoactive magno-cellular visual system
(e.g., Green et al., 1994a,b; Schechter et al., 2003; Slaghuis, 2004;
Butler et al., 2007). A full review is beyond the scope and goal
of this article [for critical reviews, see Skottun and Skoyles (2007,
2009)]. We just like to mention that most masking research in
schizophrenic patients investigated A-type masking whereas the
dual channel model is mainly proposed to explain B-type mask-
ing (non-monotonic masking functions with strongest masking
for SOAs of around 50ms). Also the shine-through paradigm
reveals A-type masking characteristics and stimuli are biased
rather toward the parvo-cellular than the magnocellular system.
Our proposal shares many similarities with early models on
visual masking deficits in schizophrenia where a key component
is target storage in an iconic memory. The iconic memory pro-
tects target related activity to be overwritten by themask.Masking
deficits in schizophrenia patients were proposed to occur by a
dysfunctional storage mechanism or slow information transfer to
short term memory (Saccuzzo et al., 1974; Braff, 1981; Saccuzzo
and Braff, 1981; Schwartz et al., 1983; for a review see Schuck and
Lee, 1989).
SUMMARY
We found strong deficits with the shine-through masking
paradigm in schizophrenic patients (Herzog et al., 2004), in
accordance with many other studies on visual masking (Saccuzzo
et al., 1974; Braff, 1981; Saccuzzo and Braff, 1981; Green et al.,
1994a,b). Also patients with other functional psychoses than
schizophrenia show strong masking deficits; however, there are
no deficits in unipolar depressive patients (Chkonia et al., 2012).
The shine-through masking paradigm is a potential endopheno-
type of schizophrenia because, amongst other findings, relatives
of schizophrenic patients show masking deficits (Chkonia et al.,
2010), masking deficits occur before the onset of schizophrenia in
adolescents with psychosis (Holzer et al., 2009), and in healthy
students with high schizotypy scores (Cappe et al., 2012). On
the neural level, we found reduced EEG traces (Plomp et al.,
2013) and, on the genetic level, an abnormal SNPs related to the
cholinergic system (Bakanidze et al., 2009).
We propose the following speculative model which closes
the loop linking phenomenological findings (masking deficits)
to genetic abnormalities which, in turn, cause deviant neu-
ral processing as evident in the EEG. First, visual processing
per se is largely intact in schizophrenic patients as evidenced
in good performance in visual acuity tests and the vernier
task with long vernier durations. Even for short vernier dura-
tions, only mild deficits occur. We related these deteriorations
partly to unspecific effects as they may occur from suffer-
ing from a chronic disease including severe medication effects.
Second, there are pronounced masking deficits which we relate
to specific deteriorations of target enhancement and stabiliza-
tion. Third, we propose that a deficient cholinergic system is
one out of possibly more deficient enhancement mechanisms.
Heavy smoking of patients may be an attempt to compensate
for the deficient cholinergic system. Fourth, reduced GFP in
the EEG may be an indication of deficient target enhancement.
Fifth, we view masking deficits as a manifestation of similar
enhancement deficits as they may occur in cognition, emotion,
and personality. Sixth, we do not propose that deficient target
enhancement is necessary and sufficient for schizophrenia. To
the contrary, there are schizophrenic patients without masking
deficits. On the other hand, enhancement deficits are not suffi-
cient for schizophrenia because there are healthy students with
masking deficits. In addition, there are potentially many sys-
tems that contribute to information enhancement and likely a
combination of these mechanisms has to be deviant to cause
schizophrenia.
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